Enhanced tumor antigen response through oncolytic HSV virotherapy
This innovative approach leverages oncolytic HSV for tumor antigen expression to boost T and B cell responses against gliomas. By combining virotherapy with antigen-presenting cell loading, it aims to enhance durable imm...